SCHEMBL7180137

SCHEMBL7180137

CCOc1cc(OC(=O)C(C)(C)C)c(C(C)(C)CC)cc1/C=C/C(=O)c1ccc(OC(=O)C(C)(C)C)cc1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 9/20 0.48
DPP4 P27487 3/20 0.48
CYP1A1 P04798 1/20 0.45
CYP1B1 Q16678 1/20 0.45
LMNA P02545 3/20 0.43
MAPT P10636 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ATM Q13315 1/20 0.43
ABCG2 Q9UNQ0 4/20 0.43
MAOB P27338 1/20 0.43
IDH1 O75874 1/20 0.43
ABCB1 P08183 1/20 0.43
UGT1A1 P22309 1/20 0.43
ABCC1 P33527 1/20 0.43
PRMT6 Q96LA8 1/20 0.43
KDM4E B2RXH2 2/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7180140 1.00 PTPN1 (0.48) PTPN1DPP4CYP1A1CYP1B1LMNA
SCHEMBL7183568 0.92 DPP4 (0.49) PTPN1DPP4CYP1A1CYP1B1ABCG2
SCHEMBL7183563 0.92 DPP4 (0.49) PTPN1DPP4CYP1A1CYP1B1ABCG2
SCHEMBL7183416 0.92 PTPN1 (0.49) PTPN1DPP4CYP1A1CYP1B1LMNA
SCHEMBL7183411 0.92 PTPN1 (0.49) PTPN1DPP4CYP1A1CYP1B1LMNA
SCHEMBL7192582 0.91 PTPN1 (0.58) PTPN1DPP4ABCG2IDH1ABCB1
SCHEMBL7192586 0.91 PTPN1 (0.58) PTPN1DPP4ABCG2IDH1ABCB1
SCHEMBL7185457 0.89 PTPN1 (0.50) PTPN1DPP4CYP1A1CYP1B1LMNA
SCHEMBL7185455 0.89 PTPN1 (0.50) PTPN1DPP4CYP1A1CYP1B1LMNA
SCHEMBL7183889 0.89 PTPN1 (0.52) PTPN1DPP4CYP1A1CYP1B1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed